Related references
Note: Only part of the references are listed.Multifunctional Mesoporous Silica Nanoparticles as a Universal Platform for Drug Delivery
Christian Argyo et al.
CHEMISTRY OF MATERIALS (2014)
18F-Glyco-RGD Peptides for PET Imaging of Integrin Expression: Efficient Radiosynthesis by Click Chemistry and Modulation of Biodistribution by Glycosylation
Simone Maschauer et al.
MOLECULAR PHARMACEUTICS (2014)
Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe
Evan Phillips et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Engineering of Hollow Mesoporous Silica Nanoparticles for Remarkably Enhanced Tumor Active Targeting Efficacy
Feng Chen et al.
SCIENTIFIC REPORTS (2014)
Engineering a Hollow Nanocontainer Platform with Multifunctional Molecular Machines for Tumor-Targeted Therapy in Vitro and in Vivo
Zhong Luo et al.
ACS NANO (2013)
In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radio labeled Mesoporous Silica Nanoparticles
Feng Chen et al.
ACS NANO (2013)
Mesoporous silica nanoparticles in medicine-Recent advances
Veronika Mamaeva et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Multifunctional Nanoparticles for Drug Delivery and Molecular Imaging
Gang Bao et al.
ANNUAL REVIEW OF BIOMEDICAL ENGINEERING, VOL 15 (2013)
Synthesis of mesoporous silica nanoparticles
Si-Han Wu et al.
CHEMICAL SOCIETY REVIEWS (2013)
Integrated Hollow Mesoporous Silica Nanoparticles for Target Drug/siRNA Co-Delivery
Xing Ma et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
Targeting Multiplicity: The Key Factor for Anti-Cancer Nanoparticles
M. Gary-Bobo et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Functionalization of Mesoporous Silica Nanoparticles for Targeting, Biocompatibility, Combined Cancer Therapies and Theragnosis
Yaswanth Kuthati et al.
JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY (2013)
Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging
Sixiang Shi et al.
NANOMEDICINE (2013)
Cancer Nanomedicine: From Drug Delivery to Imaging
Edward Kai-Hua Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Integrin αvβ3-Targeted Radiotracer 99mTc-3P-RGD2 Useful for Noninvasive Monitoring of Breast Tumor Response to Antiangiogenic Linifanib Therapy but not Anti-Integrin αvβ3 RGD2 Therapy
Shundong Ji et al.
THERANOSTICS (2013)
Silica-based mesoporous nanoparticles for controlled drug delivery
Sooyeon Kwon et al.
JOURNAL OF TISSUE ENGINEERING (2013)
Engineering of Hollow Mesoporous Nanoparticles for Biomedical Applications
Yu Chen et al.
ADVANCED POROUS MATERIALS (2013)
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
Fangqiong Tang et al.
ADVANCED MATERIALS (2012)
Biocompatibility of Mesoporous Silica Nanoparticles
Tewodros Asefa et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Image-Guided Nanosystems for Targeted Delivery in Cancer Therapy
A. K. Iyer et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Radiolabeled RGD Peptides as Integrin alpha(v)beta3-targeted PET Tracers
U. Tateishi et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Radiolabelled RGD peptides for imaging and therapy
F. C. Gaertner et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)
Image guided therapy: The advent of theranostic agents
Enzo Terreno et al.
JOURNAL OF CONTROLLED RELEASE (2012)
RGD-Based Strategies To Target Alpha(v) Beta(3) Integrin in Cancer Therapy and Diagnosis
Fabienne Danhier et al.
MOLECULAR PHARMACEUTICS (2012)
Theranostic Applications of Nanomaterials in Cancer: Drug Delivery, Image-Guided Therapy, and Multifunctional Platforms
Alicia Fernandez-Fernandez et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2011)
cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging
Xiaoqiang Yang et al.
BIOMATERIALS (2011)
Positron emission tomography imaging of CD105 expression during tumor angiogenesis
Hao Hong et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
A cationic surfactant assisted selective etching strategy to hollow mesoporous silica spheres
Xiaoliang Fang et al.
NANOSCALE (2011)
Imaging guided trials of the angiogenesis inhibitor sunitinib in mouse models predict efficacy in pancreatic neuroendocrine but not ductal carcinoma
Peter Olson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Hollow/Rattle-Type Mesoporous Nanostructures by a Structural Difference-Based Selective Etching Strategy
Yu Chen et al.
ACS NANO (2010)
In Vivo Delivery of Silica Nanorattle Encapsulated Docetaxel for Liver Cancer Therapy with Low Toxicity and High Efficacy
Linlin Li et al.
ACS NANO (2010)
Theranostic agents that co-deliver therapeutic and imaging agents? Preface
J. Andrew MacKay et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Mesoporosity and Functional Group Dependent Endocytosis and Cytotoxicity of Silica Nanomaterials
Zhimin Tao et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2009)
Imaging of αvβ3 Expression by a Bifunctional Chimeric RGD Peptide not Cross-Reacting with αvβ5
Antonella Zannetti et al.
CLINICAL CANCER RESEARCH (2009)
The biocompatibility of mesoporous silicates
Sarah P. Hudson et al.
BIOMATERIALS (2008)
Cytotoxicity of mesoporous silica nanomaterials
Anthony J. Di Pasqua et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2008)
Targeting RGD recognizing integrins: Drug development, biomaterial research, tumor imaging and targeting
A. Meyer et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
The role of integrins in tumor angiogenesis
R Hwang et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2004)
MicroPET imaging of breast cancer αv-integrin expression with 64Cu-labeled dimeric RGD peptides
XY Chen et al.
MOLECULAR IMAGING AND BIOLOGY (2004)
Share Paper
